CovidChloroV1, Main, Corpus, bibRecord, 000895

Regulatory Challenges in the COVID-19 Era: The Case of Tunisia.

Identifieur interne : 000895 ( Main/Corpus ); précédent : 000894; suivant : 000896

Regulatory Challenges in the COVID-19 Era: The Case of Tunisia.

Auteurs : Dora Cherif ; Hajer Felfel ; Chema Drira ; Mariam Aounallah ; Meriem Kadri ; Mohamed Chiheb Ben Rayana ; Myriam Razgallah Khrouf

Source :

Disaster medicine and public health preparedness [ 1938-744X ] ; 2020.

RBID : pubmed:33143805

Abstract

In view of the possible disruptions in the manufacturing and supply of health products following the coronavirus disease 2019 (COVID-19) pandemic, the Tunisian medicines regulatory authority was mobilized to guarantee patient safety. Teleworking has become the ultimate way of service continuity. The planning was revised according to health priorities. Work procedures were set online. A minimum list of medicines known as "medicines of health and strategic interest" was established. The Directorate of Pharmacy and Medicines (DPM) has been working on updating medicines stock data. A provisional suspension of authorizations for medicines export for 1 mo was decided. A fast-track procedure allowing the validation of alternative sources of raw materials has been put in place. An appeal for a fast track manufacture of hydroalcoholic gel/solutions was launched. A Monitored Emergency Use of Unregistered and Investigational Interventions (MEURI) procedure has been adopted in order to dispense off-label prescriptions of hydroxychloroquine and azithromycin combination. Focus groups were organized in order to set up therapeutic trials exploring possible strategies of COVID-19 treatment, such as serotherapy and BCG vaccine. This proactive and anticipatory policy has made it possible to meet the health challenges dictated by this crisis.

DOI: 10.1017/dmp.2020.432
PubMed: 33143805
PubMed Central: PMC7943945

Links to Exploration step

pubmed:33143805

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Regulatory Challenges in the COVID-19 Era: The Case of Tunisia.</title>
<author><name sortKey="Cherif, Dora" sort="Cherif, Dora" uniqKey="Cherif D" first="Dora" last="Cherif">Dora Cherif</name>
<affiliation><nlm:affiliation>Directorate of Pharmacy and Medicines, Tunis, Tunisia.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Felfel, Hajer" sort="Felfel, Hajer" uniqKey="Felfel H" first="Hajer" last="Felfel">Hajer Felfel</name>
<affiliation><nlm:affiliation>Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>National medicines Control Laboratory, Tunis, Tunisia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Drira, Chema" sort="Drira, Chema" uniqKey="Drira C" first="Chema" last="Drira">Chema Drira</name>
<affiliation><nlm:affiliation>Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Marrow Bone Transplant Center, Tunis, Tunisia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Aounallah, Mariam" sort="Aounallah, Mariam" uniqKey="Aounallah M" first="Mariam" last="Aounallah">Mariam Aounallah</name>
<affiliation><nlm:affiliation>Directorate of Pharmacy and Medicines, Tunis, Tunisia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kadri, Meriem" sort="Kadri, Meriem" uniqKey="Kadri M" first="Meriem" last="Kadri">Meriem Kadri</name>
<affiliation><nlm:affiliation>Directorate of Pharmacy and Medicines, Tunis, Tunisia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ben Rayana, Mohamed Chiheb" sort="Ben Rayana, Mohamed Chiheb" uniqKey="Ben Rayana M" first="Mohamed Chiheb" last="Ben Rayana">Mohamed Chiheb Ben Rayana</name>
<affiliation><nlm:affiliation>Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>National medicines Control Laboratory, Tunis, Tunisia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Razgallah Khrouf, Myriam" sort="Razgallah Khrouf, Myriam" uniqKey="Razgallah Khrouf M" first="Myriam" last="Razgallah Khrouf">Myriam Razgallah Khrouf</name>
<affiliation><nlm:affiliation>Directorate of Pharmacy and Medicines, Tunis, Tunisia.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:33143805</idno>
<idno type="pmid">33143805</idno>
<idno type="doi">10.1017/dmp.2020.432</idno>
<idno type="pmc">PMC7943945</idno>
<idno type="wicri:Area/Main/Corpus">000895</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000895</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Regulatory Challenges in the COVID-19 Era: The Case of Tunisia.</title>
<author><name sortKey="Cherif, Dora" sort="Cherif, Dora" uniqKey="Cherif D" first="Dora" last="Cherif">Dora Cherif</name>
<affiliation><nlm:affiliation>Directorate of Pharmacy and Medicines, Tunis, Tunisia.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Felfel, Hajer" sort="Felfel, Hajer" uniqKey="Felfel H" first="Hajer" last="Felfel">Hajer Felfel</name>
<affiliation><nlm:affiliation>Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>National medicines Control Laboratory, Tunis, Tunisia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Drira, Chema" sort="Drira, Chema" uniqKey="Drira C" first="Chema" last="Drira">Chema Drira</name>
<affiliation><nlm:affiliation>Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Marrow Bone Transplant Center, Tunis, Tunisia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Aounallah, Mariam" sort="Aounallah, Mariam" uniqKey="Aounallah M" first="Mariam" last="Aounallah">Mariam Aounallah</name>
<affiliation><nlm:affiliation>Directorate of Pharmacy and Medicines, Tunis, Tunisia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kadri, Meriem" sort="Kadri, Meriem" uniqKey="Kadri M" first="Meriem" last="Kadri">Meriem Kadri</name>
<affiliation><nlm:affiliation>Directorate of Pharmacy and Medicines, Tunis, Tunisia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ben Rayana, Mohamed Chiheb" sort="Ben Rayana, Mohamed Chiheb" uniqKey="Ben Rayana M" first="Mohamed Chiheb" last="Ben Rayana">Mohamed Chiheb Ben Rayana</name>
<affiliation><nlm:affiliation>Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>National medicines Control Laboratory, Tunis, Tunisia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Razgallah Khrouf, Myriam" sort="Razgallah Khrouf, Myriam" uniqKey="Razgallah Khrouf M" first="Myriam" last="Razgallah Khrouf">Myriam Razgallah Khrouf</name>
<affiliation><nlm:affiliation>Directorate of Pharmacy and Medicines, Tunis, Tunisia.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Disaster medicine and public health preparedness</title>
<idno type="eISSN">1938-744X</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">In view of the possible disruptions in the manufacturing and supply of health products following the coronavirus disease 2019 (COVID-19) pandemic, the Tunisian medicines regulatory authority was mobilized to guarantee patient safety. Teleworking has become the ultimate way of service continuity. The planning was revised according to health priorities. Work procedures were set online. A minimum list of medicines known as "medicines of health and strategic interest" was established. The Directorate of Pharmacy and Medicines (DPM) has been working on updating medicines stock data. A provisional suspension of authorizations for medicines export for 1 mo was decided. A fast-track procedure allowing the validation of alternative sources of raw materials has been put in place. An appeal for a fast track manufacture of hydroalcoholic gel/solutions was launched. A Monitored Emergency Use of Unregistered and Investigational Interventions (MEURI) procedure has been adopted in order to dispense off-label prescriptions of hydroxychloroquine and azithromycin combination. Focus groups were organized in order to set up therapeutic trials exploring possible strategies of COVID-19 treatment, such as serotherapy and BCG vaccine. This proactive and anticipatory policy has made it possible to meet the health challenges dictated by this crisis.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">33143805</PMID>
<DateRevised><Year>2021</Year>
<Month>03</Month>
<Day>12</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1938-744X</ISSN>
<JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year>
<Month>Nov</Month>
<Day>04</Day>
</PubDate>
</JournalIssue>
<Title>Disaster medicine and public health preparedness</Title>
<ISOAbbreviation>Disaster Med Public Health Prep</ISOAbbreviation>
</Journal>
<ArticleTitle>Regulatory Challenges in the COVID-19 Era: The Case of Tunisia.</ArticleTitle>
<Pagination><MedlinePgn>1-2</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1017/dmp.2020.432</ELocationID>
<Abstract><AbstractText>In view of the possible disruptions in the manufacturing and supply of health products following the coronavirus disease 2019 (COVID-19) pandemic, the Tunisian medicines regulatory authority was mobilized to guarantee patient safety. Teleworking has become the ultimate way of service continuity. The planning was revised according to health priorities. Work procedures were set online. A minimum list of medicines known as "medicines of health and strategic interest" was established. The Directorate of Pharmacy and Medicines (DPM) has been working on updating medicines stock data. A provisional suspension of authorizations for medicines export for 1 mo was decided. A fast-track procedure allowing the validation of alternative sources of raw materials has been put in place. An appeal for a fast track manufacture of hydroalcoholic gel/solutions was launched. A Monitored Emergency Use of Unregistered and Investigational Interventions (MEURI) procedure has been adopted in order to dispense off-label prescriptions of hydroxychloroquine and azithromycin combination. Focus groups were organized in order to set up therapeutic trials exploring possible strategies of COVID-19 treatment, such as serotherapy and BCG vaccine. This proactive and anticipatory policy has made it possible to meet the health challenges dictated by this crisis.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cherif</LastName>
<ForeName>Dora</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Directorate of Pharmacy and Medicines, Tunis, Tunisia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Felfel</LastName>
<ForeName>Hajer</ForeName>
<Initials>H</Initials>
<Identifier Source="ORCID">https://orcid.org/0000-0001-9577-3599</Identifier>
<AffiliationInfo><Affiliation>Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>National medicines Control Laboratory, Tunis, Tunisia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Drira</LastName>
<ForeName>Chema</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Marrow Bone Transplant Center, Tunis, Tunisia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Aounallah</LastName>
<ForeName>Mariam</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Directorate of Pharmacy and Medicines, Tunis, Tunisia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kadri</LastName>
<ForeName>Meriem</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Directorate of Pharmacy and Medicines, Tunis, Tunisia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ben Rayana</LastName>
<ForeName>Mohamed Chiheb</ForeName>
<Initials>MC</Initials>
<AffiliationInfo><Affiliation>Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>National medicines Control Laboratory, Tunis, Tunisia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Razgallah Khrouf</LastName>
<ForeName>Myriam</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Directorate of Pharmacy and Medicines, Tunis, Tunisia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>11</Month>
<Day>04</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Disaster Med Public Health Prep</MedlineTA>
<NlmUniqueID>101297401</NlmUniqueID>
<ISSNLinking>1935-7893</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">health planning organizations</Keyword>
<Keyword MajorTopicYN="N">health-care economics and organizations</Keyword>
<Keyword MajorTopicYN="N">public health</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>11</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>11</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>11</Month>
<Day>4</Day>
<Hour>5</Hour>
<Minute>32</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">33143805</ArticleId>
<ArticleId IdType="pii">S1935789320004322</ArticleId>
<ArticleId IdType="doi">10.1017/dmp.2020.432</ArticleId>
<ArticleId IdType="pmc">PMC7943945</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>N Engl J Med. 2020 Mar 26;382(13):1268-1269</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32109011</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Public Health. 2020 May;5(5):e243-e244</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32275858</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Surg. 2020 Jun;78:185-193</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32305533</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Hum Behav. 2020 May;4(5):460-471</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32355299</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000895 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000895 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:33143805
   |texte=   Regulatory Challenges in the COVID-19 Era: The Case of Tunisia.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:33143805" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Regulatory Challenges in the COVID-19 Era: The Case of Tunisia.

Regulatory Challenges in the COVID-19 Era: The Case of Tunisia.

Source :

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki